I70.544 Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot

Name of the Condition

• Common Name: Atherosclerosis of Left Leg Bypass Graft with Heel and Midfoot Ulceration
• Medical Term: Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot
• ICD-10 Code: I70.544

Summary

Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot involves plaque buildup in a biological graft (e.g., donor tissue) used to bypass blocked arteries in the left leg, specifically affecting the heel and midfoot region, with accompanying ulceration. This narrowing reduces blood flow to the limb, potentially leading to tissue damage or complications if not managed. Nonautologous grafts are derived from sources other than the patient’s own body, such as donor veins or arteries.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. Over time, these deposits harden and narrow the vessel, restricting blood flow. The process may be accelerated by factors like graft material properties, surgical technique, or systemic atherosclerotic disease affecting other vessels. Ulceration can occur when reduced blood flow leads to tissue breakdown, particularly in weight-bearing areas like the heel and midfoot.

Risk Factors

• Age (more common in older adults)
• History of atherosclerotic disease
• Hypertension (high blood pressure)
• Hyperlipidemia (elevated cholesterol or triglycerides)
• Smoking or tobacco use
• Diabetes mellitus
• Obesity or sedentary lifestyle
• Poor diet (high in saturated fats, trans fats, or sodium)

Symptoms

• Leg pain or cramping during activity (claudication)
• Reduced pulse or coldness in the left leg
• Visible ulceration on the heel or midfoot
• Skin discoloration (e.g., pallor or cyanosis)
• Numbness or tingling in the affected limb
• Slow-healing wounds or tissue breakdown

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging, and laboratory tests. A physical exam may reveal reduced pulses, skin changes, or ulceration. Imaging studies like Doppler ultrasound, angiography, or CT angiography can assess blood flow and graft patency. Laboratory tests may include lipid profiles or glucose levels to identify underlying risk factors. Documentation should specify the location of ulceration (heel and midfoot) and the type of bypass graft (nonautologous biological).

Treatment Options

Treatment focuses on improving blood flow, managing symptoms, and promoting ulcer healing. Options may include medications (e.g., antiplatelet agents, statins, or vasodilators), wound care for ulcers, and lifestyle modifications (e.g., smoking cessation, diet changes). In severe cases, revascularization procedures (e.g., graft revision or additional bypass) may be necessary. Multidisciplinary care involving vascular specialists, podiatrists, and wound care teams is often recommended.

Prognosis and Follow-Up

Prognosis depends on the severity of atherosclerosis, ulceration, and response to treatment. Early intervention can improve outcomes, but advanced disease may lead to limb-threatening complications. Regular follow-up is essential to monitor graft function, ulcer healing, and risk factor management. Patients should be educated on signs of worsening symptoms (e.g., increased pain or non-healing wounds) to seek timely care.

Complications

• Limb ischemia or gangrene
• Infection of ulcerated tissue
• Graft failure or occlusion
• Chronic pain or disability
• Amputation (in severe cases)

Lifestyle & Prevention

• Quit smoking or avoid tobacco use
• Maintain a heart-healthy diet (low in saturated fats, high in fiber)
• Engage in regular physical activity (as tolerated)
• Manage blood pressure, cholesterol, and blood sugar levels
• Practice proper foot care (e.g., daily inspections, moisturizing, avoiding injury)
• Follow prescribed medications and treatment plans

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden severe leg pain or swelling
• Non-healing or worsening ulceration
• Signs of infection (e.g., redness, pus, fever)
• Changes in skin color (e.g., darkening or bluish discoloration)
• Numbness or loss of sensation in the foot or toes

Tips for Medical Coders

When coding I70.544, ensure documentation specifies:

• Nonautologous biological bypass graft(s) of the left leg
• Ulceration of the heel and midfoot (distinct from other leg regions)
• Laterality (left leg) and graft type (nonautologous biological)
• Clinical correlation with symptoms, imaging, or treatment to support the diagnosis. Avoid assumptions about graft type or ulcer location without clear documentation.